Is 5 units of Lantus (insulin glargine) nightly a possible dosage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is 5 Units of Lantus Nightly a Possible Dosage?

Yes, 5 units of Lantus (insulin glargine) nightly is a possible dosage, particularly for patients who are insulin-sensitive or just beginning insulin therapy. This dosage falls within the lower end of recommended starting doses for basal insulin therapy.

Recommended Starting Doses for Insulin Glargine

  • For type 2 diabetes patients, the typical initial dose is 10 units or 0.1-0.2 units/kg of body weight once daily 1
  • For patients on enteral/parenteral feeding requiring insulin, a reasonable starting point is 5 units of NPH/detemir insulin every 12 hours or 10 units of insulin glargine every 24 hours 2
  • For insulin-naive type 2 diabetes patients, the recommended starting dose is 0.1-0.2 units/kg/day 1
  • For type 1 diabetes, total daily insulin requirements typically range from 0.4 to 1.0 units/kg/day, with 0.5 units/kg/day being typical for metabolically stable patients 2

When 5 Units May Be Appropriate

  • For very insulin-sensitive patients (e.g., lean individuals, elderly patients) 1
  • For patients with mild hyperglycemia requiring minimal insulin supplementation 1
  • When initiating insulin therapy cautiously to avoid hypoglycemia 3
  • For patients transitioning from oral medications to insulin therapy 2

Titration Guidelines

  • After initiating Lantus, the dose should be titrated by 2-4 units every 3-4 days until the target fasting blood glucose is reached 1
  • For patients with fasting glucose ≥180 mg/dL, consider increasing the dose by 4 units 1
  • Most patients can be taught to uptitrate their own insulin dose, typically adding 1-2 units (or 5-10% for higher doses) once or twice weekly if fasting glucose levels remain above target 2

Important Considerations

  • Insulin glargine provides basal insulin coverage but does not address postprandial glucose excursions, which may require additional rapid-acting insulin at mealtimes 4
  • Lantus can be administered at any time of day (morning or bedtime) as long as it's given at the same time each day 5
  • The risk of hypoglycemia is lower with insulin glargine compared to NPH insulin, particularly for nocturnal hypoglycemia 3
  • Timely dose titration is crucial for achieving glycemic goals 1

Common Pitfalls to Avoid

  • Delaying appropriate dose titration can lead to prolonged periods of suboptimal glycemic control 1
  • Not adjusting doses based on self-monitoring of blood glucose levels 1
  • Overbasalization (using higher than necessary basal insulin doses) can mask insufficient mealtime insulin coverage 1
  • Failure to recognize that insulin requirements may change with weight changes, illness, or changes in physical activity 2

While 5 units is lower than the typical starting dose of 10 units, it represents a cautious approach that may be appropriate for certain patients, with the expectation that the dose will be titrated upward as needed to achieve glycemic targets.

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin glargine (Lantus).

International journal of clinical practice, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.